BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pachman LM, Nolan BE, DeRanieri D, Khojah AM. Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy. Curr Treatm Opt Rheumatol 2021;7:39-62. [PMID: 34354904 DOI: 10.1007/s40674-020-00168-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Boyarchuk O, Kuka A, Yuryk I. Clinical and autoantibody phenotypes of juvenile dermatomyositis. Reumatologia 2022;60:281-91. [PMID: 36186835 DOI: 10.5114/reum.2022.119045] [Reference Citation Analysis]
2 Toplak N, Pimpale Chavan P, Rosina S, Dallos T, Rotem Semo O, Aguiar CL, Khubchandani R, Ravelli A, Patwardhan A. Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series. Front Pediatr 2022;9:810785. [DOI: 10.3389/fped.2021.810785] [Reference Citation Analysis]
3 Khojah A, Morgan G, Pachman LM. Clues to Disease Activity in Juvenile Dermatomyositis: Neopterin and Other Biomarkers. Diagnostics 2021;12:8. [DOI: 10.3390/diagnostics12010008] [Reference Citation Analysis]
4 Dressler F, Price M, Meyer-bahlburg A. Seronegative polyartikuläre juvenile idiopathische Arthritis mit Lungenbeteiligung – oder wohl doch nicht? Arthritis und Rheuma 2021;41:415-417. [DOI: 10.1055/a-1671-9202] [Reference Citation Analysis]
5 Khojah A, Liu V, Morgan G, Shore RM, Pachman LM. Changes in total body fat and body mass index among children with juvenile dermatomyositis treated with high-dose glucocorticoids. Pediatr Rheumatol Online J 2021;19:118. [PMID: 34376205 DOI: 10.1186/s12969-021-00622-1] [Reference Citation Analysis]